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patients and affect leukocyte and stem cell migration
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Fortuna4, Jouni Uitto1, Andy South1, and Olga Igoucheva1
1Department of Dermatology and Cutaneous Biology, Jefferson Medical College, Thomas 
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2University of Monterrey, Monterrey, México
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Abstract
Hereditary epidermolysis bullosa (EB) is associated with skin blistering and the development of 
chronic non-healing wounds. Although clinical studies have shown that cell-based therapies 
improve wound healing, recruitment of therapeutic cells to blistering skin and to more advanced 
skin lesions remains a challenge. Here, we analyzed cytokines and chemokines in blister fluids 
(BF) of patients affected by dystrophic, junctional and simplex EB. Our analysis revealed high 
levels of CXCR1, CXCR2, CCR2 and CCR4 ligands, particularly dominant in dystrophic and 
junctional EB. In vitro migration assays demonstrated preferential recruitment of CCR4+ 
lymphocytes and CXCR1+, CXCR2+ and CCR2+ myeloid cells toward EB-derived BF. Immuno-
phenotyping of skin-infiltrating leukocytes confirmed substantial infiltration of the EB-affected 
skin with resting (CD45RA+) and activated (CD45RO+) T cells and CXCR2+ CD11b+ cells, many 
of which were identified as CD16b+ neutrophils. Our studies also showed that abundance of 
CXCR2 ligand in BF also creates a favorable milieu for the recruitment of the CXCR2+ stem cells, 
as validated by in vitro and in-matrix migration assays. Collectively, this study identified several 
chemotactic pathways that control the recruitment of leukocytes to the EB-associated skin lesions. 
These chemotactic axes could be explored for the refinement of the cutaneous homing of the 
therapeutic stem cells.
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Introduction
Heritable epidermolysis bullosa (EB) is a group of mechanobullous disorders characterized 
by skin fragility. Based on the level of tissue separation within the dermo-epidermal 
basement membrane zone (BMZ), EB is divided into 4 categories: simplex (EBS), junctional 
(JEB), dystrophic (DEB) and Kindler syndrome (KS). Each sub-type of EB is associated 
with mutations in specific genes encoding proteins associated with mechanical stability of 
the BMZ. Despite the diversity of the phenotypic manifestations, all EB forms are 
accompanied by tissue separation and development of blisters and erosions following trauma 
to the skin. In physiological conditions, healing starts from coagulation of blood in ruptured 
blood vessels and release of different signaling molecules that recruit various cell types to 
the site of injury. This leads to an acute local inflammatory response, activation of tissue 
repair, regeneration, and restoration of tissue integrity.
A plethora of cytokines have been shown to participate in dynamic wound healing process, 
including one superfamily of small (8–15 kD) proteins called chemokines (Efron and 
Moldawer, 2004). Once secreted from damaged tissue, chemokines orchestrate wound 
healing-associated inflammation, angiogenesis and recruitment of extracellular matrix-
producing cells. Wound healing studies on rodent models demonstrated that aberrant 
chemotactic signaling leads to the unresolved inflammation, chronic wounds, accumulation 
of extracellular matrix, scarring and necrosis. (Luster et al., 1998, Rennekampff et al., 2000). 
At present, however, only limited information is available regarding cytokines and 
chemokines in EB-affected skin.
In this study, we examined chemotactic signatures in blister fluid (BF) collected from 
patients affected by different types of EB. We identified chemotactic signals that can 
potentially contribute to impaired blister healing and define chemotactic axes improving 
recruitment of therapeutic stem cells to EB-affected skin. This work highlights the 
inflammatory and immune activities in the blistering skin of EB patients, thus, providing 
potential markers of disease activity and treatment effect.
Results
Plasma and blister fluids of EB-affected patients contain pro-inflammatory chemokines 
and cytokines
Chemokines were analyzed in plasma and BF collected from EB patients (DEB (n=59), JEB 
(n=6), EBS (n=10), and DDEBP (n=2) using antibody arrays. The clinical characteristics of 
EB patients are summarized in Table S1. Out of 38 chemokines, high levels of CXCL7, 
CCL5, CCL19, and CCL4 were detected in the plasma. Out of all, only CCL11, CXCL8, 
CCL15, CXCL7, and CXCL12 showed statistically significant difference (p<0.05) in plasma 
of EB patients when compared to healthy controls (Fig. 1a).
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In the majority of BF from EB-affected patients, high levels of CCL27, CCL24, Gro-family 
(CXCL1, CXCL2, CXCL3), CXCL8, CXCL10, CCL2, CCL4, CCL15, CXCL7 and CCL5 
were detected (Fig. 1b) independent of age, gender and blister location (data not shown). A 
side-by-side comparison of EB-derived fluids and control samples collected from frost-bite 
or burn-induced blisters of healthy donors showed a similar chemotactic pattern overall (Fig 
1b). When chemotactic content of the advanced blisters (>98 h from onset) was compared to 
early blisters (≤24 h from onset), the majority of early DEB and JEB blisters contained 2-3 
times lower levels of chemokines than advanced blisters (Fig. 1c, Fig. S1). On the contrary, 
early EBS blisters contained significantly higher levels of CXCL5, Gro family chemokines, 
CXCL8 and CCL2 chemokines than advanced lesions. CCL15, CCL17 and CCL20 were 
also consistently higher in early EBS than in other EB types (Fig. 1c). To validate array data, 
several identified chemokines were quantified by Multi-Analyte ELISArray. Analysis 
confirmed high levels of CXCL8 (up to 1000 pg/ml), Gro-family chemokines (CXCL1/2/3) 
(up to 400 pg/ml), CCL2, CCL4 and CCL5 in EB-associated BF (Fig. 1d).
Elevated levels of cytokines such as IL-1β, IL-2, IL-6 and reduced levels of TNFα have 
been reported in the serum of DEB and EBS patients, suggesting that EB could be classified 
as a systemic inflammatory disease rather than a skin-limited disorder (Annicchiarico et al., 
2015). Cytokine antibody array analysis showed that BF of all EB types share a similar 
profile: out of 88 examined cytokines, adiponectin (ACRP30), angiogenin and IL-6 were 
detected at the highest levels (Fig. 2). Levels of BDNF, EGF, ICAM-1, IGFBP-1, 2, 6, 
MSPα and osteoprotegirin were also consistently high in all EB types. BF also contained 
pro-inflammatory cytokines, including IL-1, IL-6, TNFα, IL15; however, some of these 
cytokines were counterbalanced by antagonistic soluble receptors, including IL-1ra and 
sTNF-R1 and sTNF-R2 (Fig 2).
Blister fluid-derived chemokines modulate leukocyte migration in vitro
Elevated levels of several chemokines in BF suggested that inflammatory cells expressing a 
restricted set of chemokine receptors could be mobilized to blistering skin and contribute to 
EB pathology. Thus, CXCR1 and CXCR2-expressing cells could be recruited to blistered 
skin by CXCL1/2/3/7/8, while CCR2+ could be recruited by CCL2, CCR4+ cells by CCL5, 
CCL17 and CCL22, and CCR3+ cells by CCL5, CCL11 and CCL24 ligands (Fig 1d). To 
better characterize leukocyte recruitment and contribution to EB pathology and to define 
chemotactic axes for recruitment of therapeutic stem cells to EB-affected skin, human 
peripheral blood mononucleated cells (PBMC) isolated from healthy donors were used for 
the in vitro migration in Transwell chambers. A dose- and time-dependent migration of 
leukocytes was observed toward BF (Fig 3a, b). At 60 min, PBMC migration was 
substantially enhanced by adding BF into lower chambers. At 120 min, a 5-fold increase in 
migration was observed relative to control. Adding BF into both upper and lower chambers 
inhibited PBMC migration (Fig. 3b).
To define chemotactic axes directing leukocyte migration, expression of lead chemokine 
receptors for BF-associated chemokines was further examined by FACS. Lymphocytes that 
migrated to the lower chambers in response to BF during the first 60 min predominantly 
expressed CCR4 and CCR5 receptors for CCL2/17/22 and CCL4/5 BF-derived chemokines, 
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respectively (Fig. 3c, e). The majority of migrating myeloid cells expressed CXCR2, CCR2 
and CXCR1, which are receptors for the most abundant BF chemokines, including CCL2, 
CXCL1/2/3, CXCL7 and CXCL8 (Fig. 3d, e). To identify fast-responding leukocytes, 
migration of lead chemokine receptor-positive cells was analyzed at 30 min. Based on side 
scatter/fluorescence data, the majority of migrating CXCR2+ and CXCR1+ cells were 
myeloid (Fig. 3f). This population was also highly positive for CCR2, whereas migrating 
lymphocytes were mostly positive for CCR4. Migrating CCR3+ and CCR5+ cells were also 
detected but to a considerably lesser extent (Fig. 3f). Taken together, these findings suggest 
that circulating leukocytes could be preferentially recruited to EB-affected blistering skin via 
engagement of CXCR1, CXCR2, CCR2 and CCR4 receptors.
Chemokines enhance recruitment of CXCR2+ leukocytes to EB-affected skin
Recruitment of leukocytes to the EB-affected skin was further validated on the tissue array 
containing samples of 3 EB types (DEB n=15; EBS n=8; JEB n=5). Indirect 
immunofluorescence analysis confirmed a 3- to 5-fold increase in skin-infiltrating CD45+ 
leukocytes in all EB samples. A majority of the infiltrating cells were represented by 
CD45RO+, CD45RA+ T cells and CD11b+ myeloid cells (Fig. 4a, b). Clusters of CD45 
infiltrating cells were identified as CXCR2+ leukocytes, which were more predominant in 
blistering than non-blistering skin in all EB types (Fig. 5a, b). Moreover, in RDEB skin at 
least half of the CD11b+ cells were identified as CXCR2+ cells with at least two-thirds of 
them represented by CD16b+CXCR2+ neutrophils (Fig. 5c, d). Overall, this analysis 
confirmed our in vitro data on leukocyte recruitment by BF-derived chemokines and 
suggested that only few chemokine receptors, including CXCR2, can direct leukocyte 
migration to EB-affected skin.
Blister fluid-derived chemokines induce migration of CXCR1+ and CXCR2+ therapeutic 
stem cells in collagenous matrix
Several clinical investigations involving systemic transplantation of potentially therapeutic 
stem cells have reported inefficient engraftment of the cells to the cutaneous tissue (Nagy et 
al., 2011, Petrof et al., 2015, Wagner et al., 2010). With the aim of improving cutaneous 
homing of transplanted stem cells, we recently investigated chemotactic signals in a RDEB 
mouse model and identified several potential chemotactic axes directing stem cells to the 
RDEB skin (Alexeev et al., 2016). Based on this data, we hypothesize that adipose-derived 
stem cells (ADSC) expressing CXCR1 and/or CXCR2 receptors on the cell surface could be 
effectively recruited to EB-affected skin. However, our recent studies demonstrated that only 
a small percentage (4%-6%) of ADSC is CXCR1- and CXCR2-positive (Alexeev et al., 
2016). To generate human ADSC that uniformly express candidate receptors, we stably 
transduced ADSC with plasmids encoding human CXCR1 and CXCR2 and showed robust 
expression of receptors on the surface of up to 70% of cells (Fig. S2). Then, CXCR1+ and 
CXCR2+ cells were used for in vitro migration assay in Transwell chambers with EB-
derived BF or culture media (control). More than 30% of CXCR1+ cells migrated to the 
lower chamber in response to BF (Fig. 6a, b). CXCR2-driven migration was more 
pronounced and BF concentration-dependent: more than 70% of CXCR2+ ADSC migrated 
to the lower chamber in response to BF-derived chemokines (Fig. 6a, b).
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Directional migration of the ADSC was further validated by the in vitro migration assay in 
collagenous matrix where stem cells and BF-containing collagenous layers were separated 
by at least 5 mm thick collagenous matrix. Forced expression of CXCR1 and CXCR2 led to 
a directional migration of the ADSC toward the BF-containing layer throughout the 
collagenous matrix against gravity (Fig. 6c). No substantial migration of the cells was 
detected in the absence of BF (not shown) or when unselected ADSC were used (Fig. 6c). 
Taken together, these studies showed that CXCR1 and CXCR2 chemokine receptors mediate 
directional migration of ADSC toward chemotactic gradients provided by BF-derived 
chemokines.
Discussion
Chemokines play an important role in wound healing by orchestrating an intricate sequence 
of cellular events that are divided into inflammatory, proliferative and remodeling phases. 
The function of certain chemokines in wound healing (e.g. CXCL8) is well-characterized, 
whereas information about others is only now emerging (Hasegawa et al., 2013, Kroeze et 
al., 2012, Kroeze et al., 2009, van den Broek et al., 2014). There is still a substantial gap in 
understanding the role of chemokines in the healing of trauma-induced skin blisters and 
particularly in hereditary blistering disorders. Better understanding of these molecules in EB 
could provide opportunities for new therapeutic approaches aimed at reducing blister 
formation and improving cell-based therapies.
To date, several studies on EB patient-derived material have demonstrated increased levels 
of IL-1β and IL-6 in plasma and CXCL8 (IL-8) in BF of DEB and EBS patients. Increased 
levels of CCL2, CCL19 and CCL20 were observed in the skin of EBS mice (Annicchiarico 
et al., 2015, Heinemann et al., 2011, Lettner et al., 2013, Roth et al., 2009). Our prior studies 
also identified reduced transcription of CCl27, CSF3, CX3CL1 and CXCL14 and higher 
expression of CXCL18 in the non-blistering skin of JEB and DEB transgenic mice (Alexeev 
et al., 2013). Proteomic screens of chemotactic molecules in BF of DEB blistering mouse 
skin showed consistently high levels of CCL6, chemerin, CCL8, CCL9/CCL10, CCL12, 
CXCL1, CXCL2, CXCLl2, CXCL5, and CDF (Alexeev et al., 2016). As presented here, 
analysis of human BF showed a somewhat similar pattern. High levels of the CXC 
chemokines containing Glu-Leu-Arg (ELR) motif (Gro family, CXCL5, CXCL7, and 
CXCL8) were detected in early blisters. In acute wound healing, these chemokines are 
responsible for the first step of the inflammatory phase, rapid recruitment of neutrophils 
(Van Damme et al., 1997), which begins within minutes to hours of wounding and typically 
lasts for 4 days (Romagnani et al., 2004). Contrary to the acute wound healing, advanced 
blisters and EB-affected skin contained high levels of the ELR chemokines (with the 
exception of CXCL5) and showed persistent infiltration with neutrophils. These 
observations suggest an abnormal initiation of blister healing.
The initial stage of the inflammatory phase of wound healing ends with the disappearance of 
neutrophils from the wound site through apoptosis, followed by recruitment of myeloid cells 
through CCL2, CCL3, CCL4, CCL5 and CCL7 chemokines during the first week after 
wounding (Engelhardt et al., 1998, Jackman et al., 2000, Wetzler et al., 2000). Consistent 
with this data, we also detected higher levels of CCL5, CCL2 and CCL4 in advanced blisters 
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compared to early blisters. Similar to chronic wounds (Schwarz et al., 2013), persistently 
high levels of these chemokines could be disadvantageous for blister healing.
Because ELR chemokines, particularly CXCL8, act as stimulators of neoangiogenesis and 
re-epithelialization (Engelhardt et al., 1998), it is plausible that consistently high levels of 
these chemokines accompanied by high level of angiogenin in BF may lead to unbalanced 
blister healing and development of chronic wounds in EB patients. Angiogenin possesses 
both ribonuclease and angiogenic activities (Gao and Xu, 2008), and it hydrolyzes RNA and 
modulates protein synthesis. In addition, it binds to a 42 kDa smooth muscle type alpha-
actin to activate proteolytic cascades leading to degradation of the laminin and fibronectin 
layers of the basement membrane (Tello-Montoliu et al., 2006) and allowing endothelial 
cells to penetrate perivascular tissue. Although we did not find any significant differences in 
angiogenin level in different forms of EB by ELISA (Fig. S3), it is plausible that a 
consistently high level in BF is one of the precipitating factors in DEB- and JEB-associated 
SCC development and, along with ELR chemokines, in the development of chronic wounds.
In the remodeling phase of wound healing, chemokines could be responsible for excessive 
degradation of ECM through induction of matrix metalloproteinase (MMP) expression by 
skin resident cells and through sustained recruitment of neutrophils known to secrete various 
MMPs. It is particularly evident in chronic wounds exhibiting neutrophil-dependent 
impairment in re-epithelialization and increased ECM degradation (Dovi et al., 2003, Martin 
et al., 2003). Neutrophil-derived proteases like cathepsin G, elastase, and protease3 cleave 
elastin, fibronectin, laminin, vitronectin, and collagen IV (Witko-Sarsat et al., 2000), and 
they interfere with re-epithelialization and the formation of a new BMZ in the dermo–
epidermal junction (Briggaman et al., 1984). Neutrophil-secreted MMPs (MMP8 
(collagenase-2), MMP9 (gelatinase B) and MMP2 (gelatinase A) also interfere with BMZ 
formation by cleaving fibrillar collagens (MMP8) and type IV collagen (MMP2 and 9). This 
is underscored by high levels of active MMP8 and high gelatinase activity in chronic 
wounds (Bullen et al., 1995, Moor et al., 2009, Nwomeh et al., 1999, Nwomeh et al., 1998, 
Wysocki et al., 1993). Also, these MMPs can cleave and activate CXCL5 and CXCL8 
(Tester et al., 2007) and process CCL2 to generate CCR1, 2, and 3 antagonists that inhibit 
leukocyte recruitment (McQuibban et al., 2002). Although our analysis demonstrated that 
several cytokines and chemokines could be associated with EB severity, prognostic value of 
these molecules requires further biostatistical evaluation and modeling in a larger cohort of 
patients.
Our analysis also revealed a high level of adiponectin (ACRP30) in EB-derived BF. This 
protein hormone modulates several metabolic processes, including glucose regulation and 
fatty acid oxidation (Diez and Iglesias, 2003). Since adiponectin level correlates with body 
fat percentage (Ukkola and Santaniemi, 2002), its presence in BF may also have a 
prognostic/evaluative value for EB patients, particularly children, who could be chronically 
malnourished with signs of subcutaneous fat depletion (Gruskay, 1988).
Presented analysis is of particular importance to the development of cell-based therapies for 
the treatment and management of EB. Recent clinical trials demonstrated that 
allotransplantation of bone marrow-derived stem cells into DEB patient alleviated some 
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disease-associated symptoms attributed to paracrine effects rather than donation of the 
therapeutic protein by donor cells to the BMZ (Nagy et al., 2011, Petrof et al., 2015, Wagner 
et al., 2010). In fact, inefficient recruitment of the adult stem cells to damaged skin has been 
documented in wound healing studies (Ojeh et al., 2015, Shingyochi et al., 2015). 
Previously, we analyzed BF in mouse models mimicking DEB (Fritsch et al., 2008, 
Heinonen et al., 1999) and identified several potential chemotactic axes for enhanced 
recruitment of therapeutic stem cells to blistering mouse skin (Alexeev et al., 2016). 
Although a side by side comparison of chemokines in mouse and human BF showed 
substantial differences, it is apparent that BF of both species contain high levels of CXCR1 
and CXCR2 ligands and these chemokine receptors could be harnessed to drive migration of 
the therapeutic stem cells to blistering skin. Our current analysis of blister fluid-induced 
human stem cell migration in vitro is consistent with this notion. Proteome data are also 
supportive of the recent findings showing elevated CXCL12 levels in serum of EB-affected 
patients (Ujiie et al., 2017). Yet, CXCL12 -CXCR4 chemotactic axis was mostly associated 
with dissemination of cancers to the lymph node, bone, lung, brain, and liver (Sun et al., 
2010, Teicher and Fricker, 2010). In the skin, CXCL12 expression was associated with skin-
infiltrating dendritic cells, pericytes, endothelial cells and fibroblasts (Avniel et al., 2006, 
Rezk et al., 2017), as well as with emigration of dendritic cells from the cutaneous tissue 
(Kabashima et al., 2007). In fact, data presented by Ujiie et al. also demonstrate that 
CXCL12 expression in the EB-affected skin is mostly associated with skin infiltrating cell. 
Therefore, the role of CXCL12 in recruitment of cell to the skin remains to be further 
elucidated.
As discussed previously (Alexeev et al., 2013, 2016), migration of cells to peripheral tissues 
is a two-step process requiring (i) extravasation of cells from the blood stream, and (ii) 
migration of cells within the peripheral tissue (skin). Usually, separate sets of chemokines 
regulate these two processes. Extravasation of memory T cells from dermal blood vessels is 
mediated by CCR4 ligands (CCL17, CCL22 and CCL5) (Tubo et al., 2011), whereas 
migration of cells within the tissue requires activation of other receptors (e.g., CCR10) by 
epithelia-derived CCL27 (Alexeev et al., 2013). Separation of extravasation and in-tissue 
migration chemotactic signals helps restrict migration of circulating cells to the injured sites. 
Only few chemokines, including CXCL8, can mediate both processes by inducing rolling, 
diapedesis and intra-cutaneous migration (Kohda et al., 2002). Taking into account the high 
levels of CXCL7 (another CXCR2 ligand) in the plasma of EB-affected patients, it is also 
plausible that CXCL7 activates rolling of CXCR2+ cells, whereas other CXCR2 ligands 
mediate intracutaneous migration. These findings, along with our recent animal studies 
(Alexeev et al., 2016), strongly support the hypothesis that a CXCR2+ population of stem 
cells could be effectively recruited to EB-affected skin and is advantageous for cell-based 
EB therapy via systemic transplantation.
Collectively, robust analysis of BF- and plasma-associated chemokines and cytokines 
revealed a number of EB skin-associated chemotactic gradients, which may contribute to EB 
pathology by altering recruitment of leukocytes and creating a favorable milieu for the 
progression of the skin blisters to non-healing wounds. This study also revealed several 
chemotactic axes involving CXCR1/2 and CCR4 ligands that could be further exploited for 
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the effective recruitment and homing of the therapeutic stem cells to EB-affected skin and 
the improvement of the cells-based therapies.
Materials and Methods
Blister fluids and skin from EB patients
Blister fluids, blood and skin biopsies from EB patients were obtained with support from 
DEBRA Chile and DEBRA Mexico according to ethical committee rules and individual 
country's regulations. Clinical features of the patients are presented in Table S1. The study 
was not considered as human subject research.
Chemokine and cytokine antibody arrays
Human Chemokine Antibody Arrays C1 and Human Cytokine Antibody Array C1000 
(RayBiotech, Inc., Norcross, GA) were used to detect chemokines and cytokines in plasma 
and blister fluids according to manufacturer protocols. Analysis of the obtained data was 
done with RayBiotech Analysis Tools software.
ELISA assay
Multi-Analyte (Qiagen, Valencia, CA) and Angiogenin (RayBiotech) ELISA assays were 
used to detect most common chemokines and angiogenin as devised by manufacturers.
Cell culture
ADSC were isolated from human foreskin and characterized and cultured according to 
previously established protocol (Alexeev et al., 2014). PBMC were purchased from Stem 
Cell Technologies (Cambridge, MA) and cultured in RPMI1640 media supplemented with 
10% FBS (Thermo/Fisher, Grand Island, NY).
Fluorescence-activated cell sorting (FACS) analysis
Cells were incubated with fluorochrome-conjugated chemokine receptor-specific antibodies 
(BioLegend, San Diego, CA; Table S2) (Alexeev et al., 2014). Expression of chemokine 
receptors was assessed on Guava EasyCyte system and analyzed using GuavaSoft 2.7 
software (Millipore, Billerica, MA). Gating of different leukocyte populations was done 
based on the assessment of side scatter (SSC) vs forward scatter (FSC).
Histological and immunofluorescence analyses
Frozen tissues were cryosectioned and 7 μm sections were fixed in 4% paraformaldehyde 
(PFA) and used for indirect immunofluorescence analysis using antigen-specific primary 
antibodies (Table S2). Immunocomplexes were detected with fluorochrome-labeled 
secondary antibodies (Thermo/Fisher, Grand Island, NY). Slides were covered with 
Fluorosafe reagent (Millipore, Billerica, MA) and analyzed by fluorescent microscopy.
Nucleofection
Nucleofection of plasmids was done using Amaxa Nucleofector II system (Lonza, Basel, 
Switzerland) with Kit V and T-027 program.
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In vitro migration in transwell chambers and collagenous matrix
PBMC (3×106 cells) or ADSC (1×106 cells) were loaded into the top chamber of the 8-μm 
pore size Transwell chambers (Corning Costar, Scranton, PA). Control or BF-containing 
culture media was placed into a lower chamber. Migrated cells were collected from the 
lower chambers and the undersides at indicated times, enumerated and used for FACS 
analysis. For in-matrix migration, ADSC were fluorescently labeled with Vibrant DiO dye 
(Thermo/Fisher) and plated in collagen gel on the bottom of the Transwell chamber. A 
separating collagenous layer was created on top. The migration unit was completed by 
creating BF-containing collagen gel on the top. Migration unit was placed into Transwell 
plate and incubated for 4 days under standard tissue culture condition. After fixation in 
formalin and freezing, 10 μm cryosections were used for analysis.
More detailed information on material and methods is available as supplementary material.
Statistical analysis
Comparison of the data was performed using Student 2-tailed t-test; p<0.05 was considered 
statistically significant.
A more detailed description of experimental procedures is given in the Supplementary 
Material and Methods.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Proteomic screens of chemokines in plasma and blister fluids of EB-affected patients
(a-c) Antibody array analysis of the chemokines in plasma (a) and blister fluids (b, c) of EB 
affected patients. Asterisks indicate chemokines which levels are significantly different 
(p<0.05) in EB samples relative to control. Check marks indicate consistently high 
chemokines. Panel a - blood plasma from healthy donors was used as a control. Panel (b) - 
blister fluids from frost bite-and burn-induced blisters of healthy donors was used as a 
control. The data was collected from independent arrays with duplicate measurements for 
each chemokine using all samples listed in Table S1. Data are presented as a mean pixel 
density ± SD. EB types are indicated in the inserts. (c) Comparison of the selected 
chemotactic molecules in early and advanced blisters of EB patients. EB forms (DEB (D), 
JEB (J) and EBS (S)) and chemokines are listed below the columns. (d) Multi-Analyte 
ELISA analysis of common human chemokines in selected DEB (n=18), JEB (n=6) and 
EBS (n=6) BF samples. The values are presented as the mean chemokine concentration 
(pg/ml) ± SD. Detected chemokines and their cognate receptors are shown below the 
columns.
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Figure 2. Proteome analysis of cytokines in blister fluids of EB-affected patients
The 88 most common cytokines were assessed in BF by protein array analysis. Cytokines 
are listed below the columns. Data are presented as a mean pixel density ± SD. EB types are 
indicated in the insert. Curved arrows are placed above typical pro-inflammatory cytokines 
and crossed circles are placed above typical anti-inflammatory cytokines.
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Figure 3. EB blister fluid-derived chemokines affect leukocyte migration in vitro
(a, b) Concentration (a) and time-dependent (b) BF-induced leukocyte migration in 
Transwell migration chambers. Dilution of BF and time indicated below the columns. 
Conditions are shown on panel inserts. The data were collected from three independent 
experiments in triplicate and presented as migration (fold difference) relative to control 
(culture media in both chambers) ± SD. (c, d) FACS-based analysis of selected chemokine 
receptors on BF-responding lymphocytes (c) and myeloid cells (d). Representative profiles 
illustrate chemokine receptor-positive cells retained in the top chamber (Top) or migrated to 
the lower chamber and the underside (Bottom) of Transwell migration chamber within 60 
min. Detected chemokine receptors are shown on the inserts. Percentage of receptor-positive 
cells is shown above the profiles. (e) Scatter plots showing percentage and median of 
chemokine receptor-positive translocated (Bottom) and sessile (Top) cells depicted on panels 
c and d. Statistical significance (p-value) is shown above the plots. (f) Short-term analysis of 
selected chemokine receptor-positive populations migrated in Transwell chambers in 
response to BF at 1:20 and 1:60 dilutions (as indicated) within 30 min. Detected chemokine 
receptors are shown above representative histograms. Inserts show distribution of receptor-
positive populations (side scatter/fluorescence) exposed to culture media (CM) and blister 
fluid (BF). Percentage of migrated chemokine-receptor-positive population is shown in 
inserts. Histogram markers define a threshold of chemokine-receptor positive cells.
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Figure 4. EB-affected skin is infiltrated with T lymphocytes and myeloid cells
(a) Immuno-phenotyping of infiltrating leukocytes in normal (control) and non-blistering 
EB-affected skin using CD45, CD45RO, CD45RA and CD11b antibodies (green). EB types 
appear to the left of the micrographs. Detected antigens appear on the top. Blue - DAPI 
nuclei staining. Scale bar - 100 μm. (b) Quantitation of skin-infiltrating CD45RO+ and 
CD45RA+ T cells and CD11b+ myeloid cells. Analysis was done on 5 random sections from 
3 independent biopsies of control and EB-affected skin. Data are presented as number and 
percentage of antigen-positive cells per microscopic field ± SD. Infiltration was compared 
using t-test. p-value ≤ 0.05 was considered statistically significant.
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Figure 5. EB-affected skin is infiltrated with CXCR2+ leukocytes
Infiltration of the DEB, JEB and EBS-affected blistering and non-blistering skin with 
CD45+ and CXCR2+ leukocytes. EB types are indicated above representative images. 
Detected antigens (in corresponding color) are shown at the bottom of the panel. The blister 
cavity (BC) is outlined by dotted line. White arrowheads point to representative groups of 
CD45+ CXCR2+ leukocytes. Quantitation of lymphocytic infiltrate in control (C) and EB-
affected skin was done on 10 random microscopic fields of blistering and non-blistering skin 
for each EB type, averaged and presented as a percentage of CD45+ cells per microscopic 
field ± SD. Skin phenotype is shown in inserts. All samples achieved statistical significance 
when compared to control skin (p<0.05). (c) Characterization of skin-infiltrating CXCR2+ 
cells in control and RDEB-affected skin. Detected antigens (in respective colors) are shown 
to the left of the panels. On all representative images: Blue - DAPI nuclear staining; Scale 
bar - 100 μm. Single channel images are presented in Supplementary materials (Figs. S5a 
and S5c). (d) Quantitation of CXCR2+-infiltrating leukocytes in control and RDEB-affected 
skin (shown in inserts). The data are presented as a mean number of antigen-positive cells 
(shown below the columns) per microscopic field ± SD. Statistical significance (p-value) is 
shown above the columns.
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Figure 6. EB-derived blister fluids support migration of CXCR1+ and CXCR2+ ADSC
(a) Representative FACS profiles of CXCR1+ and CXCR2+ ADSC in the Transwell 
migration assay. Percentage of retaining (top chamber) and migrated (bottom chamber) cells 
is indicated in inserts: Orange - cell migration without BF (Control); Blue and Green - cell 
migration toward BF at 1:20 and 1:60 dilution, respectively. Histogram markers define a 
threshold of chemokine-receptor positive cells. (b) Analysis of retaining and migrating 
CXCR1+ and CXCR2+ ADSC in the Transwell chambers. Data were collected from 2 
independent experiments in triplicates. Data are presented as scatter plots depicting 
percentage of CXCR1+ and CXCR2+ cells. Statistical significance (p-value) is shown above 
the plots. (c) Analysis of BF-induced ADSC migration in collagenous matrix. Top left - 
scheme of the in-matrix migration unit. PM - porous membrane; ADSC - ADSC-containing 
collagenous gel; Col - separating collagenous layer; BF - blister fluid-containing 
collagenous gel; CM - culture media. Arrow indicates direction of migration. Representative 
images of cross sections of migration units are shown on the right: top row - migration of the 
unselected ADSC toward culture media (CM) and blister fluids (BF); bottom row - 
migration of CXCR1+ and CXCR2+ ADSC toward BF. Blue - DAPI nuclear staining; Green 
- vibrant DiO-labeled ADSC; Red - CXCR1+ or CXCR2+ ADSC detected by indirect 
immunofluorescence. Scale bar - 100 μm. Single channel images are presented in 
Supplementary materials (Fig. S6c). Bottom left - quantitative assessment of ADSC 
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migration in collagenous matrix. Migration is calculated as percentage of total (open 
columns) and CXCR1- or CXCR2-positive (red columns) ADSC migrated less than 100 or 
more than 200 μm per microscopic field ± SD. Conditions are indicated below the columns.
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